118 related articles for article (PubMed ID: 21767172)
1. Proton therapy for head and neck cancer: rationale, potential indications, practical considerations, and current clinical evidence.
Mendenhall NP; Malyapa RS; Su Z; Yeung D; Mendenhall WM; Li Z
Acta Oncol; 2011 Aug; 50(6):763-71. PubMed ID: 21767172
[TBL] [Abstract][Full Text] [Related]
2. Proton radiation therapy for head and neck cancer.
Chan AW; Liebsch NJ
J Surg Oncol; 2008 Jun; 97(8):697-700. PubMed ID: 18493920
[TBL] [Abstract][Full Text] [Related]
3. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
4. The potential of proton beam radiation therapy in head and neck cancer.
Ask A; Björk-Eriksson T; Zackrisson B; Blomquist E; Glimelius B
Acta Oncol; 2005; 44(8):876-80. PubMed ID: 16332595
[TBL] [Abstract][Full Text] [Related]
5. IMRT in the treatment of head and neck cancer: is the present already the future?
Cozzi L; Fogliata A
Expert Rev Anticancer Ther; 2002 Jun; 2(3):297-308. PubMed ID: 12113053
[TBL] [Abstract][Full Text] [Related]
6. Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy.
Yoon M; Ahn SH; Kim J; Shin DH; Park SY; Lee SB; Shin KH; Cho KH
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1477-85. PubMed ID: 19879701
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
8. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
9. Spot-scanning proton therapy for malignant soft tissue tumors in childhood: First experiences at the Paul Scherrer Institute.
Timmermann B; Schuck A; Niggli F; Weiss M; Lomax AJ; Pedroni E; Coray A; Jermann M; Rutz HP; Goitein G
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):497-504. PubMed ID: 17084557
[TBL] [Abstract][Full Text] [Related]
10. New techniques in radiation therapy for head and neck cancer: IMRT, CyberKnife, protons, and carbon ions. Improved effectiveness and safety? Impact on survival?
Thariat J; Bolle S; Demizu Y; Marcy PY; Hu Y; Santini J; Bourhis J; Pommier P
Anticancer Drugs; 2011 Aug; 22(7):596-606. PubMed ID: 21051993
[TBL] [Abstract][Full Text] [Related]
11. Clinical implementation of full Monte Carlo dose calculation in proton beam therapy.
Paganetti H; Jiang H; Parodi K; Slopsema R; Engelsman M
Phys Med Biol; 2008 Sep; 53(17):4825-53. PubMed ID: 18701772
[TBL] [Abstract][Full Text] [Related]
12. A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas.
Kozak KR; Adams J; Krejcarek SJ; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):179-86. PubMed ID: 19019562
[TBL] [Abstract][Full Text] [Related]
13. Importance of patient examination to clinical quality assurance in head and neck radiation oncology.
Rosenthal DI; Asper JA; Barker JL; Garden AS; Chao KS; Morrison WH; Weber RS; Ang KK
Head Neck; 2006 Nov; 28(11):967-73. PubMed ID: 16823872
[TBL] [Abstract][Full Text] [Related]
14. Particle beam radiotherapy for head and neck tumors: radiobiological basis and clinical experience.
Jereczek-Fossa BA; Krengli M; Orecchia R
Head Neck; 2006 Aug; 28(8):750-60. PubMed ID: 16804876
[TBL] [Abstract][Full Text] [Related]
15. Application of constant vs. variable relative biological effectiveness in treatment planning of intensity-modulated proton therapy.
Frese MC; Wilkens JJ; Huber PE; Jensen AD; Oelfke U; Taheri-Kadkhoda Z
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):80-8. PubMed ID: 20382482
[TBL] [Abstract][Full Text] [Related]
16. Can protons improve SBRT for lung lesions? Dosimetric considerations.
Georg D; Hillbrand M; Stock M; Dieckmann K; Pötter R
Radiother Oncol; 2008 Sep; 88(3):368-75. PubMed ID: 18405986
[TBL] [Abstract][Full Text] [Related]
17. Future issues in highly conformal radiotherapy for head and neck cancer.
Feng M; Eisbruch A
J Clin Oncol; 2007 Mar; 25(8):1009-13. PubMed ID: 17350951
[TBL] [Abstract][Full Text] [Related]
18. Taxol plus radiation for head and neck cancer.
Rosenthal DI; Carbone DP
J Infus Chemother; 1995; 5(2):46-54. PubMed ID: 8521234
[TBL] [Abstract][Full Text] [Related]
19. Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma.
Rosenthal DI; Ang KK
Semin Radiat Oncol; 2004 Apr; 14(2):153-66. PubMed ID: 15095261
[TBL] [Abstract][Full Text] [Related]
20. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck.
Haffty BG; Son YH; Wilson LD; Papac R; Fischer D; Rockwell S; Sartorelli AC; Ross D; Sasaki CT; Fischer JJ
Radiat Oncol Investig; 1997; 5(5):235-45. PubMed ID: 9372546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
